Grace Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30,237
Closed -$747K 183
2019
Q1
$747K Sell
30,237
-600
-2% -$14.3K 0.29% 94
2018
Q4
$570K Buy
30,837
+600
+2% +$14.3K 0.26% 102
2018
Q3
$776K Buy
30,237
+4,320
+17% +$98.9K 0.3% 79
2018
Q2
$602K Buy
+25,917
New +$536K 0.23% 99
2017
Q2
Sell
-12,517
Closed -$138K 95
2017
Q1
$138K Hold
12,517
0.06% 88
2016
Q4
$182K Hold
12,517
0.08% 77
2016
Q3
$307K Hold
12,517
0.13% 72
2016
Q2
$252K Hold
12,517
0.11% 73
2016
Q1
$329K Hold
12,517
0.15% 81
2015
Q4
$1.27M Sell
12,517
-3,533
-22% -$397K 0.6% 69
2015
Q3
$4.08M Hold
16,050
1.68% 17
2015
Q2
$4.08M Sell
16,050
-2,250
-12% -$499K 1.68% 17
2015
Q1
$3.63M Buy
+18,300
New +$3.25M 0.82% 61

Other funds holding BHC

Grace Capital's BHC Position: Q2 2019 in Review

Grace Capital sold out of Bausch Health (BHC) in Q2 2019, closing a stake of 30,237 shares — an estimated $747K sold.

Grace Capital first reported a position in BHC in Q1 2015 and held it in 13 quarters. The position peaked at $4.08M in Q3 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q2 2019.

  • Grace Capital reported no remaining Bausch Health position as of Q2 2019 after selling out during the quarter.
  • Grace Capital sold 30,237 Bausch Health shares in Q2 2019, an estimated $747K.
  • Grace Capital first reported a position in Bausch Health in Q1 2015 and held it in 13 quarters.
  • Grace Capital's Bausch Health position peaked at $4.08M in Q3 2015.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q2 2019.

Based on Grace Capital's 13F filing for Q2 2019, filed 14 Aug 2019.